Lifecore Biomedical Inc

LFCR | $6.33 -1.86% -1.9% 110K

(0.0% 1d) (19.4% 1m) (47.3% 1y) (0.0% 2d) (2.5% 3d) (-3.6% 7d) (-19.33% volume)
Earnings Calendar: 2023-10-05
Market Cap: $ 191,939,330
https://www.landec.com
Sec Filling | Patents | 796 employees

(US) Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.

msa brands injection food

add to watch list Paper trade email alert is off

Press-releases

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| Email alert Add to watchlist
nasdaq report

Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| 21.47% | O: 0.94% H: 8.21% C: 8.02%
business update

Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| 25.0% | O: -1.16% H: 5.88% C: 1.37%
business change update

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| -10.29% | O: -20.72% H: 3.86% C: -12.11%
management

Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| -10.29% | O: -20.72% H: 3.86% C: -12.11%
year

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Published: 2024-02-16 (Crawled : 21:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| Email alert Add to watchlist
nasdaq

Global Hyaluronic Acid Raw Material Market Forecast Report 2024-2034, Featuring Zimmer Biomet, Sanof,i AbbVie, Anika Therapeutics, Lifecore Biomedical, Salix Pharmaceuticals & LG Chem
Published: 2024-02-01 (Crawled : 00:00) - prnewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| -0.46% | O: 0.15% H: 1.86% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| 3.62% | O: 3.59% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -2.89% | O: -0.93% H: 0.0% C: 0.0%
ANIK | $26.02 0.89% 0.88% 31K

Health Technology

| 10.21% | O: -1.24% H: 2.86% C: -0.04%
report raw pharmaceuticals global market

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Published: 2024-01-12 (Crawled : 22:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| Email alert Add to watchlist
nasdaq report

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
Published: 2024-01-05 (Crawled : 13:00) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| 2.06% | O: 1.42% H: 16.38% C: 10.92%
ALC | $79.57 -1.47% 0.0% 850K

Health Technology

| 7.37% | O: -0.08% H: 0.76% C: -0.11%
series commercial

Lifecore Biomedical Provides Business Update
Published: 2023-12-13 (Crawled : 12:30) - globenewswire.com
LFCR | $6.33 -1.86% -1.9% 110K

Manufacturing

| 11.98% | O: -0.17% H: 5.39% C: 4.87%
business update

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001628280-24-001842	4	2024-01-22	2024-01-18	Sell	M	17500	0
0001628280-24-001842	4	2024-01-22	2024-01-18	Sell	F	6283	125617
0001628280-24-001842	4	2024-01-22	2024-01-18	Buy	M	17500	131900